Actively Recruiting
Cognitive Training and Brain Stimulation in Women With Post-chemotherapy Cognitive Impairment
Led by University Medicine Greifswald · Updated on 2025-04-04
52
Participants Needed
1
Research Sites
238 weeks
Total Duration
On this page
Sponsors
U
University Medicine Greifswald
Lead Sponsor
U
University of Greifswald
Collaborating Sponsor
AI-Summary
What this Trial Is About
The aim of this study is to investigate whether a high definition tDCS-accompanied intensive cognitive training of working memory leads to performance improvement in women with post-chemotherapy cognitive impairment after breast cancer treatment.
CONDITIONS
Official Title
Cognitive Training and Brain Stimulation in Women With Post-chemotherapy Cognitive Impairment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Completed chemotherapy for breast cancer at least 6 months ago
- Self-reported concerns about cognitive functioning
- Age between 18 and 65 years
- Right-handedness
You will not qualify if you...
- History of dementia before cancer treatment
- Other neurodegenerative neurological disorders, epilepsy, or seizures
- Severe untreated medical conditions preventing training participation
- History of moderate to severe substance use disorder
- Moderate to severe acute psychiatric disorders
- Contraindications to tDCS application
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Medicine Greifswald
Greifswald, Germany
Actively Recruiting
Research Team
A
Agnes Flöel, Prof.
CONTACT
D
Daria Antonenko, Dr.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here